![]() Viridos Viridos (formerly known as Synthetic Genomics) is a company that provides biotechnology solutions. | ![]() Santa Cruz Biotechnology Santa Cruz Biotechnology (SCBT) is a company engaged in the development of products for the biomedical research market. | ![]() Bruker Bruker is a company that develops, manufactures, and distributes scientific instruments and analytical and diagnostic services. | Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. | ![]() Bio-Rad Bio-Rad Laboratories is a company that develops, manufactures, and sells life science research and clinical diagnostics products.
| ![]() Genomic Health Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests. | ![]() Thermo Fisher Scientific Thermo Fisher Scientific is a company specializing in laboratory equipment, analytical instruments, reagents, consumables, and related technologies for scientific research and applied testing. | |
Founding Date | Founding Date 2005 | Founding Date 1991 | Founding Date 1960 | Founding Date 1998 | Founding Date 1952 | Founding Date 2000 | Founding Date 1956 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | |||||||
Locations | Locations San Diego, US HQ | Locations Dallas, US HQ Shanghai, CN Heidelberg, DE Paso Robles, US Santa Cruz, US Sun Valley, US | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more | Locations Hercules, US HQ South Granville, AU South Granville, AU Wien, AT Lokeren, BE Temse, BE São Paulo, BR see more | Locations Redwood City, US HQ Köln, DE Chiyoda City, JP London, GB | Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more | |
Employees | Employees 582% decrease | Employees 166 | Employees 11,0853% decrease | Employees 8,6004% decrease | Employees 7,4503% decrease | Employees 311 | Employees 125,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 8.9 b | Valuation ($) 23.3 b | Valuation ($) 9.2 b | Valuation ($) N/A | Valuation ($) 209.2 b |
Financial | |||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.4b (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) $2.6b (FY, 2025) | Revenue (est.) $394.1m (FY, 2018) | Revenue (est.) $44.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $1.9b (FY, 2025) | Cost of goods $1.5b (FY, 2025) | Cost of goods $1.2b (FY, 2025) | Cost of goods N/A | Cost of goods $26.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $1.6b (FY, 2025) | Gross profit $2.9b (FY, 2025) | Gross profit $1.3b (FY, 2025) | Gross profit N/A | Gross profit $18.2b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ($8.6m) (FY, 2025) | Net income $850m (FY, 2025) | Net income $759.9m (FY, 2025) | Net income $25.7m (FY, 2018) | Net income $6.7b (FY, 2025) |
Operating ⚠ | |||||||
Backlog | Backlog N/A | Backlog N/A | Backlog $2.1b (FY, 2022) | Backlog $657m (FY, 2024) | Backlog N/A | Backlog N/A | Backlog N/A |
Countries | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries 35 (Q1, 2023) | Countries N/A | Countries 70 (FY, 2023) |
Facilities Leased, sq. ft. | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. 445.7 k (FY, 2022) | Facilities Leased, sq. ft. 2.4 m (FY, 2024) | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A |
Remaining Performance Obligations | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations $2.3b (FY, 2022) | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations $25.3b (Q3, 2024) |
Funding | |||||||
Total funding raised | Total funding raised $ 40m | Total funding raised N/A | Total funding raised $ 24.5m | Total funding raised $ 28m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 500m |

Santa Cruz Biotechnology (SCBT) is a company engaged in the development of products for the biomedical research market.
View company
Bruker is a company that develops, manufactures, and distributes scientific instruments and analytical and diagnostic services.
View companyIllumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis.
View company
Bio-Rad Laboratories is a company that develops, manufactures, and sells life science research and clinical diagnostics products.
View company